Phreesia CFO Balaji Gandhi sells shares for over $50,000

Published 28/03/2025, 21:18

Phreesia, Inc. (NYSE:PHR) Chief Financial Officer Balaji Gandhi recently disposed of 1,827 shares of the company’s common stock. The transaction, which took place on March 26, 2025, was conducted at an average price of $27.4641 per share, resulting in total proceeds of approximately $50,176. According to InvestingPro data, the healthcare technology company currently trades below its Fair Value, with analysts maintaining a strong buy consensus and the stock showing a positive YTD return of ~8%.

The sale was part of a non-discretionary transaction under Phreesia’s mandatory sell-to-cover policy, which is designed to cover tax withholding obligations related to the settlement of restricted stock units. Following the transaction, Gandhi retains direct ownership of 103,591 shares in Phreesia. The company maintains a GREAT financial health score according to InvestingPro’s comprehensive analysis, operating with moderate debt levels and expected to achieve profitability this year.

The shares were sold across multiple transactions, with prices ranging from $27.37 to $27.775 per share. Gandhi has committed to providing detailed information on the specific prices for each transaction upon request. For deeper insights into insider trading patterns and comprehensive analysis of Phreesia’s financial metrics, investors can access the detailed Pro Research Report available on InvestingPro.

In other recent news, Phreesia Inc . has been the subject of multiple analyst reports, highlighting significant developments. Jefferies raised its price target for Phreesia from $28 to $32 while maintaining a Buy rating, citing strong fourth-quarter earnings and positive management commentary. KeyBanc Capital Markets reiterated an Overweight rating with a $30 price target, noting Phreesia’s impressive margin improvements and growth in the Network Solutions sector. Raymond (NSE:RYMD) James maintained an Outperform rating and a $30 price target, emphasizing the company’s shift towards a free cash flow-oriented narrative and strategic growth approach. Meanwhile, DA Davidson reiterated a Buy rating with a $36 price target, reflecting confidence in Phreesia’s consistent performance and potential for profit improvement. These recent developments indicate a generally positive outlook from analysts on Phreesia’s financial trajectory and strategic initiatives.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.